Celgene Global Health and DNDi expand collaboration

(Drugs for Neglected Diseases Initiative) Celgene Global Health, a division of Celgene Corporation, and the Drugs for Neglected Diseases initiative (DNDi) strengthen their collaboration with a four-year Research Collaboration Agreement to identify and optimize new drug candidates for the treatment of neglected tropical diseases (NTDs). Celgene will provide DNDi with new data and resources to accelerate clinical development of new treatments for patients with NTDs.